Explore All 3115 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | July 14, 2021 |
| Target | Dynakin |
| Sector | Life Science |
| Buyer(s) | CTI Clinical Trial and Consulting Services |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Medical Products |
CTI Clinical Trial and Consulting Services, Inc., a drug and device development organization, provides clinical trial and consulting services to the pharmaceutical and biotechnology industry.
| Deal Context for Buyer | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science | 1 of 1 |
| Type: Add-on Acquisition | 3 of 3 |
| Country: Spain | 1 of 1 |
| Year: 2021 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-16 |
Clinart
Dubai, United Arab Emirates Clinart is a regional and innovative contract research organization, offering a full-service End-to-End Solution for Phase I to IV clinical trials and NIS /RWE studies in the Middle East and North Africa region. Clinart offers direct access to 16+ MENA countries, in line with global standards and local cultures and regulations. The company's international experience, as well as our proven track record of successful trials since 2001 assures clients that Clinart is their reliable partner for the MENA region. Clinart headquarters are located in the Dubai Healthcare City - United Arab Emirates, offering direct coverage to countries in the Gulf region. In addition, its local offices in Saudi Arabia, Kuwait, Lebanon, and Egypt and home-based CRAs across the region, offer extensive direct coverage to different countries, ensuring that minor cultural differences across the MENA region are well managed by local teams. |
Buy | - |
